On June 13, JSPS and PRIMe will cohost “The 27th Japan Science Forum: Conquering All Diseases by Metaverse-based Research,” held at Cosmos Club in Washington DC, USA. We also welcome online participants; please refer to the following details to join this fruitful event.
| Date | Thursday, June 13, 2024 1:00pm – 6:00pm (EDT) Friday, June 14, 2024 2:00am – 7:00am (JST) |
| Format | Hybrid (Onsite & Online) |
| Venue | Cosmos Club (2121 Massachusetts Ave, NW, Washington DC, USA) *On-site participation is by invitation only. Everyone is welcome to participate online. |
| Registration | Register from JSPS Washington Office Website |
| Theme | Conquering All Diseases by Metaverse-based Research |
| Speakers | Nishida Kohji (Osaka University WPI-PRIMe Director) Takanori Takebe (Cincinnati Children’s Hospital/Osaka University WPI-PRIMe) Elisa Domínguez-Hüttinger (Universidad Nacional Autónoma de México/Osaka University WPI-PRIMe) Takahiro Nemoto (Osaka University WPI-PRIMe) Nozomu Yachie (The University of British Colombia/Osaka University WPI-PRIMe) |
| Moderator | Kazuhiro Sakurada (Osaka University WPI-PRIMe/Keio University) |
[Overview of the symposium]
Until now, the causes of diseases that are caused solely by genetic or environmental factors have beenelucidated, and this development has led to longer lifespans. Yet, diseases such as diabetes, heart failure, anddementia, which develop with age, are currently rapidly increasing. Many of these conditions are caused by acombination of genetic and environmental factors, making them difficult to overcome with conventionalapproaches, and therefore necessitating new approaches. In response to this, the Premium Research Institute forHuman Metaverse Medicine (PRIMe) was launched at Osaka University in Japan in 2022 as part of the WorldPremier International Research Center Initiative (WPI) program. PRIMe aims to overcome all diseases by creatingnew scientific fields and developing disease prevention and treatment methods in the metaverse. The finaldestination of conquering all diseases is an ambitious goal that has persisted throughout human history.
At this symposium, after a keynote speech by WPI-PRIMe Center Director Koji Nishida, we will discussreplications of diseases using organoids (miniature organs, such as a set of liver, gallbladder, and spleen) andother cutting-edge technology. Further, we will discuss the Human Biodigital Twin, which integrates thosemeasurement data obtained from organoids and clinical data by utilizing information and mathematical science . Infuture, we would like to share the Human Metaverse, which is an information platform that will hold this BiodigitalTwin, with researchers and medical professionals around the world, and we also would like to discuss about futureresearch directions.